Fundraising FoxTernaryTx
4 known investors
Find your way into TernaryTx
Each arrow is one introduction. Sign up to fill in the first one.
365 people can intro you to Chris
Ask David Yeow to introduce you to Chris Tame
You →David · together at Chemtura →Chris
102 people can intro you to Andrew
Ask Jamie Chen to introduce you to Andrew Potterton
You →Jamie · together at Evotec →Andrew
Sign up to find every way you can get introduced to TernaryTx
- Your email: who you already know at TernaryTx, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the TernaryTx team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Ternary develops AI-driven drug discovery technology focused on targeted protein degradation and induced proximity platforms. The company serves pharmaceutical and biotech organizations seeking computational approaches to identify novel therapeutic targets.
Founders & leadership
CT
Chris TameCEO & Co-FounderChris Tame is CEO and co-founder of Ternary, which develops AI-driven drug discovery technology. He has experience building machine learning products for drug design and target identification, with expertise in targeted protein degradation approaches.
AP
Andrew PottertonCTO & Co-FounderAndrew Potterton is a structural bioinformatician with 10 years of industry experience who co-founded Ternary, an AI-driven drug discovery platform for targeted protein degradation.
Investors · 4
Frequently asked questions
- What does TernaryTx do?
- Ternary develops AI-driven drug discovery technology focused on targeted protein degradation and induced proximity platforms. The company serves pharmaceutical and biotech organizations seeking computational approaches to identify novel therapeutic targets.
- Who founded TernaryTx?
- TernaryTx was founded by Chris Tame, Andrew Potterton.
- Who are TernaryTx's investors?
- TernaryTx's investors include Daphni, i&i Biotech Fund, Pace Ventures, UK Innovation & Science Seed Fund.